CAS: 618-94-0; 3-Nitrobenzhydrazide

上下游产品

CAS号618-95-1 3-硝基苯甲酸甲酯 | CAS号618-98-4 间硝基苯甲酸乙酯 | CAS号121-92-6 间硝基苯甲酸 | CAS号610-34-4 2-硝基苯甲酸乙酯 | CAS号121-90-4 间硝基苯甲酰氯 | CAS号105686-75-7 4-amino-3-(3-ni... | CAS号5378-35-8 3-[1,3,4]噁二唑-2-苯胺 | CAS号2000-54-6 Urea,N-(3-nitro... | CAS号99-61-6 间硝基苯甲醛 | CAS号78-98-8 丙酮醛 | CAS号35219-13-7 4-(1,3,4-噁二唑-2-基)苯胺 | CAS号261623-52-3 n'-(2,2-dimethy... | CAS号2588-85-4 3-[5-(3-aminoph... | CAS号618-95-1 3-硝基苯甲酸甲酯

专利信息

专利号:US-5478947-A
优先权日:1994-07-29
标题 :Effective process for the production of 1,2,3-triazoles
发明人：SINGH INDER P; SPEVAK PAUL; PALAK BHUPINDER; AMEDJO SAMUEL; MICETICH RONALD J
权利人:SYNPHAR LAB INC
摘要:A high purity triazole is obtained by the reaction of a hydrazide of the general formula II and glyoxal followed by the treatment of the intermediate of general formula IV with ammonia. The total process is done in one pot and does not require the isolation of the intermediate IV. The triazole (I) is isolated by distillation. Synthesis of various N 1 -substituted triazoles is also described following the same procedure.

专利号:US-6291504-B1
优先权日:1999-10-20
标题:Acylsemicarbazides and their uses
发明人：NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; VIDWANS ANUP P; YUE EDDY W
权利人:DU PONT PHARM CO
摘要:The present invention relates to the synthesis of a new lass of indeno[1,2-c]pyrazol-4-ones of formula (I):that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-9 and their regulatory subunits know as cyclins A-H.This invention also provides a novel method of treating cancer or other proliferative diseases by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative diseases by administering a therapeutically effective combination of one of the compounds of the present invention and one or more other known anti-cancer or anti-proliferative agents.

专利号:US-5527920-A
优先权日:1994-11-18
标 题:Economical manufacturing process for 1,2,3-triazoles
发明人：SINGH INDER P; SPEVAK PAUL; PALAK BHUPINDER; AMEDJO SAMUEL; MICETICH RONALD G
摘要:A high quality 1,2,3-triazole is obtained in a one pot two step reaction between appropriately substituted hydrazide derivatives, dihaloethanediol and NH 3 in methanol. Synthesis of various N 1 -alkyl, N 1 -aryl, and N 1 -heterocyclic-1,2,3-triazoles is also accomplished following the same general procedure.

专利号:CN-102285935-A
优先权日:2011-08-02
标 题:Synthesis of 2,2'-(1,3-phenylene)bis{5-[4-(1,1-dimethylethyl)phenyl]}-1,3,4-oxadiazole

专利号:WO-0234721-A1
优先权日:2000-10-20
标 题:Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors
发明人：NUGIEL DAVID A; CARINI DAVID J; DI MEO SUSAN V; VIDWANS ANUP; YUE EDDY W
权利人:DU PONT PHARM CO
摘要:The present invention realtes to the synthesis fo a new class of indeno [1,2-c]pyrazol-4-ones of formula (I): that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-9 and their regulatory subunits know as cyclins A-H. The invention also provides a novel method of treating cancer or otehr profiferative disease by administering a therapeutically effective amount of one of these compounds or a pharmaceutically acceptable salt form thereof. Alternatively, one can treat cancer or other proliferative disease by administering a therapeutically effective combination of one of the compounds of teh present invention and one or more other known anti-cancer or anti-proliferative agents.

专利号:US-6613942-B1
优先权日:1997-07-01
标题 :Glucagon antagonists/inverse agonists
发明人：LING ANTHONY; GREGOR VLAD; GONZALEZ JAVIER; HONG YUFENG; KIEL DAN; KUKI ATSUO; SHI SHENGHUA; NAERUM LARS; MADSEN PETER; SAMS CHRISTIAN; LAU JESPER; PLEWE MICHAEL BRUNO; FENG JUN; TENG MIN; JOHNSON MICHAEL DAVID; TESTON KIMBERLY ANN; SIDELMANN ULLA GROVE; KNUDSEN LOTTE BJERRE
权利人:NOVO NORDISK AS
摘要:Non-peptide compounds comprising a central hydrazide motif and methods for the synthesis thereof are disclosed. The compounds act to antagonize the action of the glucagon peptide hormone.